WO2001054734A3 - Produit radiopharmaceutique utilise en therapie tumorale radio-isotopique - Google Patents

Produit radiopharmaceutique utilise en therapie tumorale radio-isotopique Download PDF

Info

Publication number
WO2001054734A3
WO2001054734A3 PCT/EP2001/000714 EP0100714W WO0154734A3 WO 2001054734 A3 WO2001054734 A3 WO 2001054734A3 EP 0100714 W EP0100714 W EP 0100714W WO 0154734 A3 WO0154734 A3 WO 0154734A3
Authority
WO
WIPO (PCT)
Prior art keywords
radiopharmaceutical
thio
glucose
tumor therapy
radionucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/000714
Other languages
English (en)
Other versions
WO2001054734A2 (fr
Inventor
Armua Pedro Ortiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molypharma SA
Original Assignee
Molypharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molypharma SA filed Critical Molypharma SA
Priority to AU39226/01A priority Critical patent/AU3922601A/en
Publication of WO2001054734A2 publication Critical patent/WO2001054734A2/fr
Publication of WO2001054734A3 publication Critical patent/WO2001054734A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un produit radiopharmaceutique contenant une molécule 5-thio-D-Glucose marquée avec un isotope 188Re destiné à être utilisé en thérapie tumorale radio-isotopique. En outre, cette invention concerne une composition de thérapie radio-isotopique contenant un produit radiopharmaceutique; et un procédé de préparation d'un radiopharmaceutique, consistant à mélanger 5-thio-D-Glucose, des ions stanneux, et une solution de l'isotope 188Re dans un solvant acceptable sur le plan pharmaceutique. Ce produit radiopharmaceutique s'applique généralement à la plupart des différents types de tumeurs liées aux différents types de cancers, lequel produit est éliminé efficacement du corps après son utilisation thérapeutique.
PCT/EP2001/000714 2000-01-28 2001-01-23 Produit radiopharmaceutique utilise en therapie tumorale radio-isotopique Ceased WO2001054734A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU39226/01A AU3922601A (en) 2000-01-28 2001-01-23 A radiopharmaceutical for radionuclide tumor therapy

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200293 2000-01-28
EP00200293.9 2000-01-28

Publications (2)

Publication Number Publication Date
WO2001054734A2 WO2001054734A2 (fr) 2001-08-02
WO2001054734A3 true WO2001054734A3 (fr) 2001-12-06

Family

ID=8170952

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/000714 Ceased WO2001054734A2 (fr) 2000-01-28 2001-01-23 Produit radiopharmaceutique utilise en therapie tumorale radio-isotopique

Country Status (2)

Country Link
AU (1) AU3922601A (fr)
WO (1) WO2001054734A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100430061B1 (ko) * 2000-03-21 2004-05-03 재단법인 아산사회복지재단 글루코스 유도체에 방사성 동위원소가 표지된 착화합물 및이를 생산하기 위한 조성물이 포함된 키트

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999020316A1 (fr) * 1997-10-20 1999-04-29 Board Of Regents, The University Of Texas System Radiotraceurs d'emission monophotonique et leurs methodes d'utilisation
EP0949265A1 (fr) * 1996-12-18 1999-10-13 Nihon Medi-Physics Co., Ltd. Heterocomplexe a nitrure de metal de transition radioactif

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0949265A1 (fr) * 1996-12-18 1999-10-13 Nihon Medi-Physics Co., Ltd. Heterocomplexe a nitrure de metal de transition radioactif
WO1999020316A1 (fr) * 1997-10-20 1999-04-29 Board Of Regents, The University Of Texas System Radiotraceurs d'emission monophotonique et leurs methodes d'utilisation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OZKER K ET AL: "BIODISTRIBUTION OF 99TMM-LABELLED 5-THIO-D-GLUCOSE", NUCLEAR MEDICINE COMMUNICATIONS,XX,XX, vol. 20, no. 11, November 1999 (1999-11-01), pages 1055 - 1058, XP001014162, ISSN: 0143-3636 *

Also Published As

Publication number Publication date
WO2001054734A2 (fr) 2001-08-02
AU3922601A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
WO1999038973A3 (fr) Composes destines au diagnostic et a la therapie du cancer du poumon et procedes d'utilisation associes
WO2000061612A3 (fr) Composes et procedes de therapie et de diagnostic du cancer du poumon
Billaud et al. Micro-flow photosynthesis of new dienophiles for inverse-electron-demand Diels–Alder reactions. Potential applications for pretargeted in vivo PET imaging
CN100381196C (zh) 得到镓-68的方法和其用途以及实施所述方法的装置
WO1999047674A3 (fr) Composes et methodes therapeutiques et diagnostiques du cancer du poumon
NO986089D0 (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer o
WO2005061009A3 (fr) Microparticules pour imagerie et radiotherapie de micro-arteres
WO2001012263A3 (fr) DOSIMETRIE POUR SOURCES DE CURIETHERAPIE A EMISSION DE NEUTRONS CALIFORNIUM-252 (252Cf) ET ENCAPSULATION, STOCKAGE ET ADMINISTRATION CLINIQUE DE CELLES-CI
AU7380500A (en) Methods for treating tumors using neutron therapy
WO2003028640A3 (fr) Methode d'adherence sur plastque in vivo destinee a des ligands de liant a des molecules induites par un rayonnement
EA200700686A1 (ru) Липосомы, включающие радиоактивный изотоп, и цитотоксический агент для комбинированной терапии
AU2003219555A8 (en) Depsipeptide for therapy of kidney cancer
ZA200007211B (en) Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis.
CN1771058B (zh) 制备放射性标记的镓络合物的微波方法
WO2004062574A3 (fr) Lieurs ameliores pour composes pharmaceutiques
WO2005025620A3 (fr) Therapie de combinaison avec des inhibiteurs de la synthase du monoxyde d'azote inductible et des agents d'alkylation
WO2001054734A3 (fr) Produit radiopharmaceutique utilise en therapie tumorale radio-isotopique
WO2001080888A3 (fr) Procede de traitement des tumeurs par therapie photodynamique
IL141645A0 (en) Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
WO2002058741A3 (fr) Traitement du cancer et d'autres maladies grace a l'administration de produits radiopharmaceutiques emettant des positrons
AU1310697A (en) Magnetic substance for local hyperthermal treatment of tumours, in particular smaller tumours
WO2000037065A3 (fr) Hormonotherapie du cancer du sein associee a un traitement au tamoxifene et aux dibenzofurannes polychlores alkyles
WO2003072061A3 (fr) Procedes et compositions pour traiter la toxicite gastro-intestinale induite par la therapie de cyto-ablation
XIA Clinical application criteria and progress in?(X) stereotatic radiotherapy
Wang et al. Research advances in sorafenib: a multiple targeted anti-tumor agent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP